Cargando…

Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications

Structural cardiac lesions are often surgically repaired using prosthetic patches, which can be biological or synthetic. In the current clinical scenario, biological patches derived from the decellularization of a xenogeneic scaffold are gaining more interest as they maintain the natural architectur...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmosi, Tiziana, Tolomeo, Anna Maria, Cirillo, Carmine, Sandrin, Debora, Sciro, Manuela, Negrisolo, Susanna, Todesco, Martina, Caicci, Federico, Santoro, Michele, Dal Lago, Eleonora, Marchesan, Massimo, Modesti, Michele, Bagno, Andrea, Romanato, Filippo, Grumati, Paolo, Fabozzo, Assunta, Gerosa, Gino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792098/
https://www.ncbi.nlm.nih.gov/pubmed/36578513
http://dx.doi.org/10.3389/fbioe.2022.1042434
_version_ 1784859560187527168
author Palmosi, Tiziana
Tolomeo, Anna Maria
Cirillo, Carmine
Sandrin, Debora
Sciro, Manuela
Negrisolo, Susanna
Todesco, Martina
Caicci, Federico
Santoro, Michele
Dal Lago, Eleonora
Marchesan, Massimo
Modesti, Michele
Bagno, Andrea
Romanato, Filippo
Grumati, Paolo
Fabozzo, Assunta
Gerosa, Gino
author_facet Palmosi, Tiziana
Tolomeo, Anna Maria
Cirillo, Carmine
Sandrin, Debora
Sciro, Manuela
Negrisolo, Susanna
Todesco, Martina
Caicci, Federico
Santoro, Michele
Dal Lago, Eleonora
Marchesan, Massimo
Modesti, Michele
Bagno, Andrea
Romanato, Filippo
Grumati, Paolo
Fabozzo, Assunta
Gerosa, Gino
author_sort Palmosi, Tiziana
collection PubMed
description Structural cardiac lesions are often surgically repaired using prosthetic patches, which can be biological or synthetic. In the current clinical scenario, biological patches derived from the decellularization of a xenogeneic scaffold are gaining more interest as they maintain the natural architecture of the extracellular matrix (ECM) after the removal of the native cells and remnants. Once implanted in the host, these patches can induce tissue regeneration and repair, encouraging angiogenesis, migration, proliferation, and host cell differentiation. Lastly, decellularized xenogeneic patches undergo cell repopulation, thus reducing host immuno-mediated response against the graft and preventing device failure. Porcine small intestinal submucosa (pSIS) showed such properties in alternative clinical scenarios. Specifically, the US FDA approved its use in humans for urogenital procedures such as hernia repair, cystoplasties, ureteral reconstructions, stress incontinence, Peyronie’s disease, penile chordee, and even urethral reconstruction for hypospadias and strictures. In addition, it has also been successfully used for skeletal muscle tissue reconstruction in young patients. However, for cardiovascular applications, the results are controversial. In this study, we aimed to validate our decellularization protocol for SIS, which is based on the use of Tergitol 15 S 9, by comparing it to our previous and efficient method (Triton X 100), which is not more available in the market. For both treatments, we evaluated the preservation of the ECM ultrastructure, biomechanical features, biocompatibility, and final bioinductive capabilities. The overall analysis shows that the SIS tissue is macroscopically distinguishable into two regions, one smooth and one wrinkle, equivalent to the ultrastructure and biochemical and proteomic profile. Furthermore, Tergitol 15 S 9 treatment does not modify tissue biomechanics, resulting in comparable to the native one and confirming the superior preservation of the collagen fibers. In summary, the present study showed that the SIS decellularized with Tergitol 15 S 9 guarantees higher performances, compared to the Triton X 100 method, in all the explored fields and for both SIS regions: smooth and wrinkle.
format Online
Article
Text
id pubmed-9792098
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97920982022-12-27 Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications Palmosi, Tiziana Tolomeo, Anna Maria Cirillo, Carmine Sandrin, Debora Sciro, Manuela Negrisolo, Susanna Todesco, Martina Caicci, Federico Santoro, Michele Dal Lago, Eleonora Marchesan, Massimo Modesti, Michele Bagno, Andrea Romanato, Filippo Grumati, Paolo Fabozzo, Assunta Gerosa, Gino Front Bioeng Biotechnol Bioengineering and Biotechnology Structural cardiac lesions are often surgically repaired using prosthetic patches, which can be biological or synthetic. In the current clinical scenario, biological patches derived from the decellularization of a xenogeneic scaffold are gaining more interest as they maintain the natural architecture of the extracellular matrix (ECM) after the removal of the native cells and remnants. Once implanted in the host, these patches can induce tissue regeneration and repair, encouraging angiogenesis, migration, proliferation, and host cell differentiation. Lastly, decellularized xenogeneic patches undergo cell repopulation, thus reducing host immuno-mediated response against the graft and preventing device failure. Porcine small intestinal submucosa (pSIS) showed such properties in alternative clinical scenarios. Specifically, the US FDA approved its use in humans for urogenital procedures such as hernia repair, cystoplasties, ureteral reconstructions, stress incontinence, Peyronie’s disease, penile chordee, and even urethral reconstruction for hypospadias and strictures. In addition, it has also been successfully used for skeletal muscle tissue reconstruction in young patients. However, for cardiovascular applications, the results are controversial. In this study, we aimed to validate our decellularization protocol for SIS, which is based on the use of Tergitol 15 S 9, by comparing it to our previous and efficient method (Triton X 100), which is not more available in the market. For both treatments, we evaluated the preservation of the ECM ultrastructure, biomechanical features, biocompatibility, and final bioinductive capabilities. The overall analysis shows that the SIS tissue is macroscopically distinguishable into two regions, one smooth and one wrinkle, equivalent to the ultrastructure and biochemical and proteomic profile. Furthermore, Tergitol 15 S 9 treatment does not modify tissue biomechanics, resulting in comparable to the native one and confirming the superior preservation of the collagen fibers. In summary, the present study showed that the SIS decellularized with Tergitol 15 S 9 guarantees higher performances, compared to the Triton X 100 method, in all the explored fields and for both SIS regions: smooth and wrinkle. Frontiers Media S.A. 2022-12-12 /pmc/articles/PMC9792098/ /pubmed/36578513 http://dx.doi.org/10.3389/fbioe.2022.1042434 Text en Copyright © 2022 Palmosi, Tolomeo, Cirillo, Sandrin, Sciro, Negrisolo, Todesco, Caicci, Santoro, Dal Lago, Marchesan, Modesti, Bagno, Romanato, Grumati, Fabozzo and Gerosa. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Palmosi, Tiziana
Tolomeo, Anna Maria
Cirillo, Carmine
Sandrin, Debora
Sciro, Manuela
Negrisolo, Susanna
Todesco, Martina
Caicci, Federico
Santoro, Michele
Dal Lago, Eleonora
Marchesan, Massimo
Modesti, Michele
Bagno, Andrea
Romanato, Filippo
Grumati, Paolo
Fabozzo, Assunta
Gerosa, Gino
Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications
title Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications
title_full Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications
title_fullStr Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications
title_full_unstemmed Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications
title_short Small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications
title_sort small intestinal submucosa-derived extracellular matrix as a heterotopic scaffold for cardiovascular applications
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792098/
https://www.ncbi.nlm.nih.gov/pubmed/36578513
http://dx.doi.org/10.3389/fbioe.2022.1042434
work_keys_str_mv AT palmositiziana smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications
AT tolomeoannamaria smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications
AT cirillocarmine smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications
AT sandrindebora smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications
AT sciromanuela smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications
AT negrisolosusanna smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications
AT todescomartina smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications
AT caiccifederico smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications
AT santoromichele smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications
AT dallagoeleonora smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications
AT marchesanmassimo smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications
AT modestimichele smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications
AT bagnoandrea smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications
AT romanatofilippo smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications
AT grumatipaolo smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications
AT fabozzoassunta smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications
AT gerosagino smallintestinalsubmucosaderivedextracellularmatrixasaheterotopicscaffoldforcardiovascularapplications